Inhalation Injury 

  • Author: Denise Serebrisky, MD; Chief Editor: Michael R Bye, MD   more...
 
Updated: Mar 22, 2012
 

Background

Although children are less likely than adults to experience significant smoke inhalation, it remains a serious and life-threatening problem in the pediatric population. Management of a child with burns and a coexistent inhalation injury requires a cohesive team of pediatric intensive care physicians, nurses, and burn specialists. Although children with burns have traditionally been cared for in adult burn units, the increased availability of physicians, nurses, and ancillary staff trained in the care of severely ill pediatric patients make the pediatric intensive care unit a superior environment. Understanding that children are not merely small adults is critical to preventing therapeutic errors that can result in disastrous iatrogenic complications.

The heat generated during combustion can cause significant thermal injury to the upper airway. Particulate matter produced during combustion (soot) can mechanically clog and irritate the airways, causing reflex bronchoconstriction. Noxious asphyxiant gases released during thermal decomposition include carbon monoxide (CO) and hydrogen cyanide. Other byproducts produced by combustion of furniture and cotton (aldehydes) or rubber and plastics (chlorine gas, ammonia, hydrocarbons, various acids, ketones) produce injury. Exposure to metal fumes and fluorocarbons, systemic toxins typically released during industrial fires, is rare in the pediatric population. Children are less likely to be affected by systemic toxins than by toxins from household products and products of smoke, including CO and cyanide poisoning.

Routine use of smoke and CO detectors in the home is designed to decrease the risk of injury by permitting early escape. However, the risk for smoke inhalation remains high in the pediatric population, and ongoing prevention efforts are important.

Next

Pathophysiology

Inhalation injury occurs in 3 ways: (1) by cell injury and pulmonary parenchymal damage by irritants, (2) hypoxemia by interruption of oxygen delivery by asphyxiants, and (3) end organ damage by systemic absorption through the respiratory tract.

Respiratory embarrassment can be broadly categorized as the result of thermal or chemical damage to the epithelial surfaces of the intrathoracic and extrathoracic airways. Secondary insult with bacterial pneumonia may occur days after inhalation, causing further cytotoxic damage. Ciliary function is impaired, leading to accumulation of airway debris. The inflammatory cascade initiates neutrophil infiltration. Macrophages within the alveoli are destroyed, allowing bacteria to proliferate. Lack of an intact epithelial barrier further facilitates the development of pneumonia.

Hypoxemia results from a decrease in inspired oxygen concentration at the scene of injury, a mechanical inability to exchange gas because of airway obstruction or parenchymal pulmonary disease, and inhibition of oxygen delivery and tissue use by toxins. With the advent of sophisticated intensive care support, patients who survive the acute injury and are successfully transported to an ICU now rarely die from isolated pulmonary disease. However, the presence of multiorgan dysfunction, a common sequela of hypoxia, substantially raises morbidity and mortality.

Because CO does not directly injure the lung, its toxic effect results from a displacement of oxygen from hemoglobin-binding sites, thereby decreasing the oxygen-carrying capacity of the blood. It not only has a 250-fold increased affinity for hemoglobin than oxygen but also shifts the oxyhemoglobin dissociation curve to the left. The leftward shift of the oxyhemoglobin dissociation curve results in further tissue hypoxia because the hemoglobin is less able to unload oxygen. CO reacts with myoglobin to further impair oxygen uptake by decreasing facilitated diffusion of oxygen into muscle. CO also interacts with several heme-containing enzymes of the electron transport chain, further impairing tissue oxygen availability.

Cyanide causes tissue asphyxiation through the inhibition of intracellular cytochrome oxidase. It blocks the final step in oxidative phosphorylation and prevents mitochondrial oxygen use. Affected cells convert to anaerobic metabolism, and lactic acidosis ensues. The organs most sensitive to cellular hypoxia are the CNS and the heart. The CNS reacts to low concentrations of cyanide through hyperventilation, thereby increasing exposure if the route is by inhalation.

Previous
Next

Epidemiology

Frequency

United States

Burns in children are 2.5 times more likely to occur by scalding rather than flame exposure. Hence, the percentage of children who experience respiratory symptoms after burns is less than that of adults who are more often exposed to smoke-producing flames. About 50% of all burn deaths are related to inhalation injuries. Early hypoxemia is a contributor to over 50% of smoke inhalation deaths, with CO intoxication accounting for as much as 80% of the fatalities.

Mortality/Morbidity

Inhalation injury significantly increases the morbidity and mortality of burns. Small children are especially vulnerable because they are less likely to escape a confined space and also have a higher minute ventilation, which increases exposure to smoke and other toxins released during pyrolysis. In addition, their relatively smaller airways will be more severely affected by airway edema and obstructing material.

Bacterial pneumonia often complicates inhalation injury within 4-5 days of presentation. This additional cellular damage can cause significant mortality days to weeks after the initial injury.

Children with acute pulmonary injury secondary to toxic inhalations generally do well once supported through the initial inflammation and damage. Most of the pulmonary damage is self-limited and resolves within 2-3 days. The degree of recovery depends on the extent of the pulmonary parenchymal injury and subsequent hypoxic damage to the organs.

Residual reactive airway disease, bronchiectasis, bronchiolitis obliterans, and interstitial fibrosis have been reported. However, the cause-and-effect relationships between toxic exposure and pulmonary sequelae remain controversial and unproven.

Airway hyperreactivity generally improves over several months following inhalation injury. However, some authors documented long-term respiratory symptoms such as cough, wheeze, and shortness of breath even after mild inhalation injury, indicating a more prolonged nature of the lung injury. The long-term effects of inhaled toxins on pulmonary function are not yet determined.

CO intoxication is a particularly serious consequence of smoke inhalation and may account for as much as 80% of fatalities from inhalation injury. Most patients who arrive alive to the emergency department make a full recovery. However, up to one third of patients with significant CO exposure develop a secondary syndrome of long-term neurologic dysfunction within 1-3 weeks after exposure. Higher cortical functions seem most severely affected. Whether the use of hyperbaric oxygen (HBO) therapy alters the outcome of delayed-onset neurologic dysfunction due to CO poisoning remains controversial. Approximately one third of patients with smoke inhalation from domestic fires also have high blood cyanide levels.

Previous
 
 
Contributor Information and Disclosures
Author

Denise Serebrisky, MD  Assistant Professor, Department of Pediatrics, Albert Einstein College of Medicine; Director, Division of Pulmonary Medicine, Lewis M Fraad Department of Pediatrics, Jacobi Medical Center; Director, Jacobi Asthma and Allergy Center for Children

Denise Serebrisky, MD is a member of the following medical societies: American Thoracic Society

Disclosure: Nothing to disclose.

Coauthor(s)

Emily B Nazarian, MD  MD, Assistant Professor of Pediatrics, Fellowship Director, Pediatric Critical Care, Golisano Children's Hospital at Strong

Emily B Nazarian, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Heidi Connolly, MD  Associate Professor of Pediatrics and Psychiatry, University of Rochester School of Medicine and Dentistry; Director, Pediatric Sleep Medicine Services, Strong Sleep Disorders Center

Heidi Connolly, MD is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Girish D Sharma, MD  Professor of Pediatrics, Rush Medical College; Senior Attending, Department of Pediatrics, Director, Section of Pediatric Pulmonology and Rush Cystic Fibrosis Center, Rush University Medical Center

Girish D Sharma, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Royal College of Physicians of Ireland

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Charles Callahan, DO  Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center

Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, and Christian Medical & Dental Society

Disclosure: Nothing to disclose.

Mary E Cataletto, MD  Director of Children's Sleep Services, Winthrop Sleep Disorders Center; Professor of Clinical Pediatrics, State University of New York at Stony Brook

Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians

Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Michael R Bye, MD  Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Whitelock-Jones L, Bass DH, Millar AJ, Rode H. Inhalation burns in children. Pediatr Surg Int. 1999;15(1):50-5. [Medline].

  2. Rorison DG, McPherson SJ. Acute toxic inhalations. Emerg Med Clin North Am. May 1992;10(2):409-35. [Medline].

  3. Weiss SM, Lakshminarayan S. Acute inhalation injury. Clin Chest Med. Mar 1994;15(1):103-16. [Medline].

  4. Carr JA, Phillips BD, Bowling WM. The utility of bronchoscopy after inhalation injury complicated by pneumonia in burn patients: results from the National Burn Repository. J Burn Care Res. Nov-Dec 2009;30(6):967-74. [Medline].

  5. Agee RN, Long JM 3rd, Hunt JL, Petroff PA, Lull RJ, Mason AD Jr, et al. Use of 133xenon in early diagnosis of inhalation injury. J Trauma. Mar 1976;16(3):218-24. [Medline].

  6. Oremus M, Hanson MD, Whitlock R, Young E, Archer C, Dal Cin A, et al. A systematic review of heparin to treat burn injury. J Burn Care Res. Nov-Dec 2007;28(6):794-804. [Medline].

  7. Jones WG, Madden M, Finkelstein J, Yurt RW, Goodwin CW. Tracheostomies in burn patients. Ann Surg. Apr 1989;209(4):471-4. [Medline]. [Full Text].

  8. Bartlett RH. Critical Care Physiology. Little, Brown and Company: Boston, Mass; 1996:68-69.

  9. Blanc PD, Galbo M, Hiatt P, Olson KR, Balmes JR. Symptoms, lung function, and airway responsiveness following irritant inhalation. Chest. Jun 1993;103(6):1699-705. [Medline].

  10. Chou KJ, Fisher JL, Silver EJ. Characteristics and outcome of children with carbon monoxide poisoning with and without smoke exposure referred for hyperbaric oxygen therapy. Pediatr Emerg Care. Jun 2000;16(3):151-5. [Medline].

  11. Clark CJ, Campbell D, Reid WH. Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet. Jun 20 1981;1(8234):1332-5. [Medline].

  12. Cohen MA, Guzzardi LJ. Inhalation of products of combustion. Ann Emerg Med. Oct 1983;12(10):628-32. [Medline].

  13. Demarest GB, Hudson LD, Altman LC. Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation. Am Rev Respir Dis. Feb 1979;119(2):279-86. [Medline].

  14. DiVincenti FC, Pruitt BA Jr, Reckler JM. Inhalation injuries. J Trauma. Feb 1971;11(2):109-17. [Medline].

  15. Haponik EF, Crapo RO, Herndon DN, Traber DL, Hudson L, Moylan J. Smoke inhalation. Am Rev Respir Dis. Oct 1988;138(4):1060-3. [Medline].

  16. Heimbach DM, Waeckerle JF. Inhalation injuries. Ann Emerg Med. Dec 1988;17(12):1316-20. [Medline].

  17. Jackson MP, Philp B, Murdoch LJ, Powell BW. High frequency oscillatory ventilation successfully used to treat a severe paediatric inhalation injury. Burns. Aug 2002;28(5):509-11. [Medline].

  18. Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. Jan 25 2005;CD002041. [Medline].

  19. Kipen HM, Rab S, Mohr S. Incidence of persistent symptoms and morbidity after inhalation exposure. American Review of Respiratory Disease. 1993;147:A113.

  20. Madnani DD, Steele NP, de Vries E. Factors that predict the need for intubation in patients with smoke inhalation injury. Ear Nose Throat J. Apr 2006;85(4):278-80. [Medline].

  21. Moritz AR, Henriques FC, McLean R. The effects of inhaled heat on the air passages and lungs: an experimental investigation. American Journal of Pathology. 1945;21:311-325.

  22. Peterson JE, Stewart RD. Absorption and elimination of carbon monoxide by inactive young men. Arch Environ Health. Aug 1970;21(2):165-71. [Medline].

  23. Pruitt BA Jr, Cioffi WG, Shimazu T, Ikeuchi H, Mason AD Jr. Evaluation and management of patients with inhalation injury. J Trauma. Dec 1990;30(12 Suppl):S63-8. [Medline].

  24. Pruitt BA Jr, Erickson DR, Morris A. Progressive pulmonary insufficiency and other pulmonary complications of thermal injury. J Trauma. May 1975;15(5):369-79. [Medline].

  25. Rossignol AM, Boyle CM, Locke JA, Burke JF. Hospitalized burn injuries in Massachusetts: an assessment of incidence and product involvement. Am J Public Health. Nov 1986;76(11):1341-3. [Medline].

  26. Ruddy RM. Smoke inhalation injury. Pediatr Clin North Am. Apr 1994;41(2):317-36. [Medline].

  27. Stone JP, Hazlett RN, Johnson JE. The transport of hydrogen chloride by soot from burning polyvinyl chloride. J of Fire Flammability. 1973;4:42.

  28. Thom SR, Keim LW. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J Toxicol Clin Toxicol. 1989;27(3):141-56. [Medline].

  29. Vogel SN, Sultan TR, Ten Eyck RP. Cyanide poisoning. Clin Toxicol. Mar 1981;18(3):367-83. [Medline].

  30. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1057-67. [Medline].

  31. Whitener DR, Whitener LM, Robertson KJ, Baxter CR, Pierce AK. Pulmonary function measurements in patients with thermal injury and smoke inhalation. Am Rev Respir Dis. Nov 1980;122(5):731-9. [Medline].

  32. Witten ML, Quan SF, Sobonya RE, Lemen RJ. New developments in the pathogenesis of smoke inhalation-induced pulmonary edema. West J Med. Jan 1988;148(1):33-6. [Medline]. [Full Text].

  33. Wright MJ, Murphy JT. Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin. J Trauma. Jul 2005;59(1):64-70. [Medline].

  34. Zikria BA, Weston GC, Chodoff M, Ferrer JM. Smoke and carbon monoxide poisoning in fire victims. J Trauma. Aug 1972;12(8):641-5. [Medline].

Previous
Next
 
Table. Inhalants[2, 3]
TypeInhalantSourceInjury/Mechanism
Irritant gasesAmmoniaFertilizer, refrigerant, manufacturing of dyes, plastics, nylonUpper airway epithelial damage
ChlorineBleaching agent, sewage and water disinfectant, cleansing productsLower airway epithelial damage
Sulfur dioxideCombustion of coal, oil, cooking fuel, smeltingUpper airway epithelial damage
Nitrogen dioxideCombustion of diesel, welding, manufacturing of dyes, lacquers, wall paperTerminal airway epithelial damage
AsphyxiantsCarbon monoxide*Combustion of weeds, coal, gas, heatersCompetes for oxygen sites on hemoglobin, myoglobin, heme-containing intracellular proteins
Hydrogen cyanideBurning of polyurethane, nitrocellulose (silk, nylon, wool)Tissue asphyxiation by inhibiting intracellular cytochrome oxidase activity, inhibits ATP production, leads to cellular anoxia
Hydrogen sulfideSewage treatment facility, volcanic gases, coal mines, natural hot springsSimilar to cyanide, tissue asphyxiant by inhibition of cytochrome oxidase, leads to disruption of electron transport chain, results in anaerobic metabolism
Systemic toxinsHydrocarbonsInhalant abuse (toluene, benzene, Freon); aerosols; glue; gasoline; nail polish remover; typewriter correction fluid; ingestion of petroleum solvents, kerosene, liquid polishes CNS narcosis, anesthetic stats, diffuse GI symptoms, peripheral neuropathy with weakness, coma, sudden death, chemical pneumonitis, CNS abnormalities, GI irritation, cardiomyopathy, renal toxicity
OrganophosphatesInsecticides, nerve gasesBlocks acetylcholinesterase, cholinergic crisis with increased acetylcholine
Metal fumesMetal oxides of zinc, copper, magnesium, jewelry makingFlulike symptoms, fever, myalgia, weakness
* Major component of smoke



† Smells like almonds, component of smoke from fires



‡ Smells like rotten eggs



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.